Wize Pharma

Wize Pharma Short-term Debt

Delisted·Jan 10, 2019

The Short-Term Debt of Wize Pharma (WIZP) as of Nov 19, 2026 is 2.64 M USD. In the previous year, Short-Term Debt was 3.20 M USD — a change of -17.76% (lower).

Short-term Debt

2.64 MUSD

YoY

-17.76%

Last updated:

Short-Term Debt of Wize Pharma is 2018 2.64 M USD. Short-Term Debt of Wize Pharma was 2017 3.20 M USD. It decreases by -17.76% lower compared to the previous year.

The Wize Pharma Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2015
3.69 M USD
Jan 1, 2016
406,000.00 USD
Jan 1, 2017
3.20 M USD
Jan 1, 2018
2.64 M USD
The Wize Pharma Short-term Debt history
YEARShort-term DebtYoY
2.64 MUSD-17.76%
3.20 MUSD+689.16%
406,000.00USD-89.00%
3.69 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Short-Term Debt of Wize Pharma is 2.64 M USD in 2018.

Short-Term Debt of Wize Pharma changed from 3.20 M USD to 2.64 M USD, representing a -17.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Wize Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Wize Pharma

All Key Metrics — Wize Pharma